Prostate Cancer

Early-onset breast cancer has highest incidence and mortality rates

Spreading this message can save lives

A series of articles look at whether the benefits for the few warrant the harms for the many

Studies show their potential, but reveal clear issues with treatment information reliability

Significant improvement in radiographic progression-free survival in BRCA-positive disease

These tests could soon become a valuable addition to current cancer screening tools

However, this technique requires more time and resources than standard techniques

Higher cardiorespiratory fitness linked to lower risk of death from colon, lung, prostate cancers

Approval limited to BRCA-positive subset

Systematic reviews suggests increased risks of cognitive adverse events, fatigue, falls

Should very low-risk and low-risk be combined into one?

Combo has potential to be new standard of care in patients with high-risk BCR, expert says

ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset

Agency asking ODAC if olaparib-abiraterone should be reserved for BRCA-positive subset